Brompton Global Healthcare Income & Growth ETF (TSX: HIG)
Canada
· Delayed Price · Currency is CAD
8.76
0.00 (0.00%)
May 16, 2024, 11:33 AM EDT
2.70% (1Y)
Assets | 53.61M |
Expense Ratio | 1.09% |
PE Ratio | 29.08 |
Dividend (ttm) | 0.66 |
Dividend Yield | 7.53% |
Ex-Dividend Date | Apr 29, 2024 |
Payout Frequency | Monthly |
Payout Ratio | 219.06% |
1-Year Return | +2.10% |
Volume | 375 |
Open | 8.76 |
Previous Close | 8.76 |
Day's Range | 8.76 - 8.76 |
52-Week Low | 7.65 |
52-Week High | 8.90 |
Beta | 0.93 |
Holdings | 26 |
Inception Date | Apr 3, 2018 |
About HIG
Brompton Global Healthcare Income & Growth ETF (HIG) is an exchange-traded fund that trades on the Toronto Stock Exchange in Canada. It is an actively managed fund that invests in global large-cap health care companies, overlaid by a covered call options.
Asset Class Equity
Category Health Care
Stock Exchange TSX
Ticker Symbol HIG
Provider Brompton
Performance
HIG had a total return of 2.10% in the past year. Since the fund's inception, the average annual return has been -5.36%, including dividends.
Top 10 Holdings
49.23% of assetsName | Symbol | Weight |
---|---|---|
Merck & Co., Inc. | MRK | 5.45% |
AstraZeneca PLC | AZN | 5.38% |
Cencora | COR | 5.38% |
Eli Lilly and Company | LLY | 5.04% |
McKesson Corporation | MCK | 4.85% |
Novo Nordisk A/S | NVO | 4.70% |
HCA Healthcare, Inc. | HCA | 4.63% |
Boston Scientific Corporation | BSX | 4.63% |
Stryker Corporation | SYK | 4.61% |
Vertex Pharmaceuticals Incorporated | VRTX | 4.55% |
Dividend History
Ex-Dividend | Amount |
---|---|
Apr 29, 2024 | 0.055 CAD |
Mar 27, 2024 | 0.055 CAD |
Feb 28, 2024 | 0.055 CAD |
Jan 30, 2024 | 0.055 CAD |
Dec 28, 2023 | 0.055 CAD |
Nov 29, 2023 | 0.055 CAD |